Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Genome-Wide Association Study Identifies New Susceptibility Loci for Esophageal Adenocarcinoma and Barrett's Esophagus

By LabMedica International staff writers
Posted on 21 Oct 2013
Results obtained during a large genome-wide association study yielded three previously unknown gene associations linked to the risk of esophageal cancer and its precursor, Barrett's esophagus. More...


Esophageal cancer (more than 60% being esophageal adenocarcinoma) affects nearly 18,000 Americans annually with more than 15,000 fatalities. A precursor syndrome, Barrett's esophagus is associated with chronic heartburn and affects an estimated one to two million Americans each year.

Both syndromes are under active study by a group of investigators comprising the international Barrett's and Esophageal Adenocarcinoma Consortium, or BEACON, an open scientific forum for research into the causes and prevention of esophageal cancer and Barrett's esophagus that involves more than 40 scientists in North America, Europe, and Australia.

In a recent study, BEACON investigators at the Fred Hutchinson Cancer Research Center (Seattle, WA, USA) pooled data and DNA specimens from 15 international studies conducted over the past 20 years to estimate the heritability of esophageal adenocarcinoma and Barrett's esophagus and identify genetic variants associated with increased risk. Ultimately, they gathered DNA samples and lifestyle risk-exposure data from more than 8,000 study participants, including about 5,500 with esophageal cancer or Barrett's esophagus and about 3,200 participants without these conditions who served as a control group. The DNA samples were genotyped using a high-density array platform that allowed for the simultaneous and accurate assessment of more than one million genetic variants.

Analysis of the data enabled the researchers to identify genetic variants at three locations – on chromosomes 3, 9 and 19. These variants were found to be associated significantly with esophageal adenocarcinoma and Barrett's esophagus. In addition, they found that a genetic variant on chromosome 16 that had been previously linked to Barrett's esophagus was also associated with an increased risk of esophageal adenocarcinoma.

"Epidemiologic findings, largely based on the work of BEACON investigators, clearly demonstrate that environmental factors such as obesity, gastroesophageal reflux, smoking, and diet are largely responsible for the rapidly increasing incidence and mortality from esophageal adenocarcinoma," said senior author Dr. Thomas L. Vaughan, professor of epidemiology at the Fred Hutchinson Cancer Research Center. "However, a growing body of evidence also suggests an important role for inherited susceptibility. These findings establish strong starting points for further epidemiologic studies to pin down the causal variants, and laboratory studies to identify the mechanisms by which the causal variants might affect the development of Barrett's esophagus and esophageal adenocarcinoma. The fact that all four of the new loci are in or near genes associated with early development of the esophagus or already associated with oncogenic activity is particularly exciting, as it implies that we may be close to finding some important pathways in the development of this highly fatal disease."

The study was published in the October 13, 2013, online edition of the journal Nature Genetics.

Related Links:

Fred Hutchinson Cancer Research Center



Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Online QC Software
Acusera 24•7
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
Automated Clinical Chemistry Analyzer
Envoy 500+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: A simple oral swab detected blood-matched inflammatory signals in children with primary ciliary dyskinesia, offering a needle-free way to monitor inflammation during routine care (Image credit: Shutterstock)

Simple Oral Swab Monitors Persistent Inflammation in Primary Ciliary Dyskinesia

Primary ciliary dyskinesia is a rare lung disease that affects about one in 7,500 to 10,000 live births worldwide. Symptoms can begin in the newborn period and progress to recurrent respiratory infections... Read more

Microbiology

view channel
Image: The study compares rapid molecular CPE diagnostics, which can return results in about one hour, with culture-based screening, which typically takes about 48 hours (Image credit: Adobe Stock)

Rapid Molecular Screening Aims to Accelerate Hospital Infection Control for CPE

Drug-resistant infections remain a critical patient-safety threat in hospitals, with carbapenemase-producing Enterobacterales (CPE) among the most urgent concerns. In England, reports of acquired carbapenemase... Read more

Pathology

view channel
Image: The VENTANA PTEN (SP218) RxDx Assay is a qualitative IHC assay for assessing PTEN protein in prostate adenocarcinoma, with staining performed using the OptiView DAB IHC Detection Kit on a BenchMark ULTRA instrument (Photo courtesy of Roche)

New Companion Diagnostic Expands Precision Medicine in Prostate Cancer

Prostate cancer is a leading cancer diagnosis in men and becomes particularly aggressive when it presents as metastatic, hormone-sensitive disease. Tumors with loss of phosphatase and tensin homolog (PTEN)... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.